CD274 and breast neoplasm: Here, we show that all the anti-PD-1 and anti-PD-L1 mAbs are able to reduce Erk phosphorylation and, unexpectedly, to induce a very significant increase of PD-1 and PD-L1 expression on lung and breast tumor cells.